Cited 278 time in
Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Park, Ji-Young | - |
| dc.contributor.author | Yuk, Heung Joo | - |
| dc.contributor.author | Ryu, Hyung Won | - |
| dc.contributor.author | Lim, Su Hwan | - |
| dc.contributor.author | Kim, Kyung Su | - |
| dc.contributor.author | Park, Ki Hun | - |
| dc.contributor.author | Ryu, Young Bae | - |
| dc.contributor.author | Lee, Woo Song | - |
| dc.date.accessioned | 2022-12-26T19:48:31Z | - |
| dc.date.available | 2022-12-26T19:48:31Z | - |
| dc.date.issued | 2017 | - |
| dc.identifier.issn | 1475-6366 | - |
| dc.identifier.issn | 1475-6374 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/15034 | - |
| dc.description.abstract | The current study was designed to assess the inhibitory activity of Broussonetia papyrifera-derived polyphenols against 3-chymotrypsin-like and papain-like coronavirus cysteine proteases. The isolated compounds were broussochalcone B (1), broussochalcone A (2), 4-hydroxyisolonchocarpin (3), papyriflavonol A (4), 3'-(3-methylbut-2-enyl)-3',4,7-trihydroxyflavane (5), kazinol A (6), kazinol B (7), broussoflavan A (8), kazinol F (9), and kazinol J (10). All polyphenols were more potent against papain-like protease (PLpro) than against 3-chymotripsin-like protease (3CL(pro)); therefore, we investigated their structural features that were responsible for this selectivity. Compound 4 was the most potent inhibitor of PLpro with an IC50 value of 3.7 mu M. The active compounds displayed kinetic behaviors, and the binding constants of their interaction with PLpro were determined from surface plasmon resonance analysis. Our results suggest B. papyrifera constituents as promising candidates for development into potential anti-coronaviral agents. | - |
| dc.format.extent | 9 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | TAYLOR & FRANCIS LTD | - |
| dc.title | Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors | - |
| dc.type | Article | - |
| dc.publisher.location | 영국 | - |
| dc.identifier.doi | 10.1080/14756366.2016.1265519 | - |
| dc.identifier.scopusid | 2-s2.0-85013792894 | - |
| dc.identifier.wosid | 000392591100043 | - |
| dc.identifier.bibliographicCitation | JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, v.32, no.1, pp 504 - 512 | - |
| dc.citation.title | JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY | - |
| dc.citation.volume | 32 | - |
| dc.citation.number | 1 | - |
| dc.citation.startPage | 504 | - |
| dc.citation.endPage | 512 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | sci | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
| dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
| dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
| dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
| dc.subject.keywordPlus | RESPIRATORY SYNDROME CORONAVIRUS | - |
| dc.subject.keywordPlus | PAPAIN-LIKE PROTEASE | - |
| dc.subject.keywordPlus | SARS-COV 3CL(PRO) | - |
| dc.subject.keywordAuthor | Broussonetia papyrifera | - |
| dc.subject.keywordAuthor | coronavirus | - |
| dc.subject.keywordAuthor | papain-like | - |
| dc.subject.keywordAuthor | protease | - |
| dc.subject.keywordAuthor | polyphenol | - |
| dc.subject.keywordAuthor | SARS | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
